Impact of the COVID-19 lockdown on patients and families with Dravet syndrome.
Adolescent
Adult
COVID-19
/ prevention & control
Child
Child, Preschool
Communicable Disease Control
Disease Progression
Epilepsies, Myoclonic
/ physiopathology
Female
Health Behavior
Health Services
/ statistics & numerical data
Humans
Infant
Male
Masks
Middle Aged
Physical Distancing
Problem Behavior
Public Policy
SARS-CoV-2
Surveys and Questionnaires
Young Adult
COVID‐19
Dravet syndrome
behavior disorders
pandemics
social isolation
telemedicine
Journal
Epilepsia open
ISSN: 2470-9239
Titre abrégé: Epilepsia Open
Pays: United States
ID NLM: 101692036
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
received:
31
07
2020
revised:
19
12
2020
accepted:
28
12
2020
entrez:
8
3
2021
pubmed:
9
3
2021
medline:
9
3
2021
Statut:
epublish
Résumé
We explored the impact of coronavirus virus 2019 (COVID-19) pandemic on patients with Dravet syndrome (DS) and their family. With European patient advocacy groups (PAGs), we developed an online survey in 10 languages to question health status, behavior, personal protection, and health services before and after lockdown. Approximately 538 European PAG members received electronic invitations. Survey ran from April 14, to May 17, 2020, with 219 answers; median age 9 year 10 months. Protection against infection was highly used prior to COVID-19, but 88% added facemask-use according to pandemic recommendations. Only one patient was tested positive for COVID-19. Most had stable epilepsy during lockdown, and few families (4%) needed emergency care during lockdown. However, behavior disorder worsened in over one-third of patients, regardless of epilepsy changes. Half of appointments scheduled prior to lockdown were postponed; 12 patients (11%) had appointments fulfilled; and 39 (36%) had remote consultations. Responders welcomed remote consultations. Half of responders were unsatisfied with psychological remote support as only few (21 families) received this support. None of the five of patient in clinical trials stopped investigational treatment. Prior adoption of protective measures against general infection might have contributed to avoiding COVID-19 infections. Protocols for the favored remote contact ought to now be prepared.
Identifiants
pubmed: 33681664
doi: 10.1002/epi4.12464
pmc: PMC7918338
doi:
Types de publication
Journal Article
Langues
eng
Pagination
216-224Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2021 The Authors. Epilepsia Open published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.
Déclaration de conflit d'intérêts
The authors have nothing to declare in relation to this manuscript. This manuscript did not receive any additional fund. We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.
Références
Epilepsia. 2011 Apr;52 Suppl 2:50-4
pubmed: 21463280
Epilepsia. 2011 Apr;52 Suppl 2:3-9
pubmed: 21463272
Epilepsia. 2015 Apr;56(4):e36-9
pubmed: 25778844
Epilepsia. 2020 Jun;61(6):1312-1314
pubmed: 32420620
Epilepsia. 2020 Jun;61(6):1166-1173
pubmed: 32353184
Epilepsia. 2019 Dec;60 Suppl 3:S17-S24
pubmed: 31904117
Epilepsy Behav. 2020 Jul;108:107094
pubmed: 32375095
Dev Med Child Neurol. 2015 Jul;57(7):628-633
pubmed: 25772213
Pediatrics. 2015 Nov;136(5):e1310-5
pubmed: 26438699
Dev Med Child Neurol. 2018 Jan;60(1):63-72
pubmed: 28984349
Rev Neurol. 2019 Jan 16;68(2):75-81
pubmed: 30638257